Your browser doesn't support javascript.
loading
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design.
Fizazi, Karim; Foulon, Stéphanie; Carles, Joan; Roubaud, Guilhem; McDermott, Ray; Fléchon, Aude; Tombal, Bertrand; Supiot, Stéphane; Berthold, Dominik; Ronchin, Philippe; Kacso, Gabriel; Gravis, Gwenaëlle; Calabro, Fabio; Berdah, Jean-François; Hasbini, Ali; Silva, Marlon; Thiery-Vuillemin, Antoine; Latorzeff, Igor; Mourey, Loïc; Laguerre, Brigitte; Abadie-Lacourtoisie, Sophie; Martin, Etienne; El Kouri, Claude; Escande, Anne; Rosello, Alvar; Magne, Nicolas; Schlurmann, Friederike; Priou, Frank; Chand-Fouche, Marie-Eve; Freixa, Salvador Villà; Jamaluddin, Muhammad; Rieger, Isabelle; Bossi, Alberto.
Affiliation
  • Fizazi K; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Saclay, Villejuif, France. Electronic address: karim.fizazi@gustaveroussy.fr.
  • Foulon S; Department of Biostatistics and Epidemiology, Institut Gustave Roussy, University of Paris-Saclay, Villejuif, France; Oncostat U1018, Inserm, Ligue Contre le Cancer, Institut Gustave Roussy, University of Paris-Saclay, Villejuif, France.
  • Carles J; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Roubaud G; Institut Bergonié 229 cours de l'Argonne, Bordeaux, France.
  • McDermott R; Cancer Trials Ireland, St Vincent's University Hospital, Dublin, Ireland.
  • Fléchon A; Centre Léon Bérard, Lyon, France.
  • Tombal B; Clinique Universitaire St Luc, Brussels, Belgium.
  • Supiot S; Institut de Cancérologie de l'Ouest, René Gauducheau, Saint-Herblain, France.
  • Berthold D; Centre Pluridisciplinaire d'Oncologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
  • Ronchin P; Centre Azureen de Cancerologie, Mougins, France.
  • Kacso G; Amethyst Radiotherapy Center, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Gravis G; Institut Paoli-Calmettes, Aix-Marseille Université, CRCM, Marseille, France.
  • Calabro F; San Camillo Forlanini Hospitals, Rome, Italy.
  • Berdah JF; Clinique Sainte Marguerite, Hyeres, France.
  • Hasbini A; Clinique Pasteur, Brest, France.
  • Silva M; Centre François Baclesse, Caen, France.
  • Thiery-Vuillemin A; CHU Jean Minjoz, Besancon, France.
  • Latorzeff I; Clinique Pasteur, Toulouse, France.
  • Mourey L; IUCT-Oncopole, Toulouse, France.
  • Laguerre B; Centre Eugène Marquis, Rennes, France.
  • Abadie-Lacourtoisie S; Institut de Cancerologie de l'Ouest, Angers, France.
  • Martin E; Centre Georges-François Leclerc, Dijon, France.
  • El Kouri C; Centre Catherine de Sienne, Nantes, France.
  • Escande A; Strasbourg Oncologie Libérale, Strasbourg, France.
  • Rosello A; Institut Català d'Oncologia, Hospital Universitari Josep Trueta, Girona, Spain.
  • Magne N; Institut de Cancérologie Lucien Neuwirth, St Priest en Jarez, France.
  • Schlurmann F; CHIC Quimper, Quimper, France.
  • Priou F; CHD Vendée, La Roche sur Yon, France.
  • Chand-Fouche ME; Centre Antoine Lacassagne, Nice, France.
  • Freixa SV; Institut Català d'Oncologia, Cap de Servei Oncologia Radioteràpica, Hospital Universitari Germans Trias, Badalona, Catalunya, Spain.
  • Jamaluddin M; Cork University Hospital, Cork, Ireland.
  • Rieger I; Unicancer, Paris, France.
  • Bossi A; Department of Radiotherapy, Institut Gustave Roussy, University of Paris-Saclay, Villejuif, France.
Lancet ; 399(10336): 1695-1707, 2022 04 30.
Article in En | MEDLINE | ID: mdl-35405085
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Year: 2022 Type: Article